123 related articles for article (PubMed ID: 37080857)
41. A brief instrument to measure health-related quality-of-life in patients with bone metastasis: validation of the German version of Bone Metastases Quality-of-Life-10 (BOMET-QoL-10).
Marschner N; Wilke J; Reschke D; Kaiser F; Schmoor C; Grugel R; Boller E
J Med Econ; 2018 Sep; 21(9):920-929. PubMed ID: 29874105
[TBL] [Abstract][Full Text] [Related]
42. Long-Term Cognitive Functioning and Psychological Well-Being in Surgically Treated Patients with Low-Grade Glioma.
Campanella F; Palese A; Del Missier F; Moreale R; Ius T; Shallice T; Fabbro F; Skrap M
World Neurosurg; 2017 Jul; 103():799-808.e9. PubMed ID: 28411105
[TBL] [Abstract][Full Text] [Related]
43. Health-related quality of life in 640 head and neck cancer survivors after radiotherapy using EORTC QLQ-C30 and QLQ-H&N35 questionnaires.
Wan Leung S; Lee TF; Chien CY; Chao PJ; Tsai WL; Fang FM
BMC Cancer; 2011 Apr; 11():128. PubMed ID: 21486431
[TBL] [Abstract][Full Text] [Related]
44. Quality of Life Perception, Cognitive Function, and Psychological Status in a Real-world Population of Glioblastoma Patients Treated With Radiotherapy and Temozolomide: A Single-center Prospective Study.
Lombardi G; Bergo E; Del Bianco P; Bellu L; Pambuku A; Caccese M; Trentin L; Zagonel V
Am J Clin Oncol; 2018 Dec; 41(12):1263-1271. PubMed ID: 29750673
[TBL] [Abstract][Full Text] [Related]
45. Quality of life in patients with limited (1-3) brain metastases undergoing stereotactic or whole brain radiotherapy : A prospective study of the DEGRO QoL working group.
Steinmann D; Vordermark D; Gerstenberg W; Aschoff R; Gharbi N; Müller A; Schäfer C; Theodorou M; Wypior HJ; Geinitz H;
Strahlenther Onkol; 2020 Jan; 196(1):48-57. PubMed ID: 31418046
[TBL] [Abstract][Full Text] [Related]
46. The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.
Li Q; Lin Y; Qiu Y; Gao B; Xu Y
Eur J Oncol Nurs; 2014 Aug; 18(4):425-35. PubMed ID: 24721179
[TBL] [Abstract][Full Text] [Related]
47. Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran.
Khoshnevisan A; Yekaninejad MS; Ardakani SK; Pakpour AH; Mardani A; Aaronson NK
Health Qual Life Outcomes; 2012 May; 10():54. PubMed ID: 22607028
[TBL] [Abstract][Full Text] [Related]
48. Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients.
Maringwa J; Quinten C; King M; Ringash J; Osoba D; Coens C; Martinelli F; Reeve BB; Gotay C; Greimel E; Flechtner H; Cleeland CS; Schmucker-Von Koch J; Weis J; Van Den Bent MJ; Stupp R; Taphoorn MJ; Bottomley A;
Ann Oncol; 2011 Sep; 22(9):2107-2112. PubMed ID: 21324954
[TBL] [Abstract][Full Text] [Related]
49. Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.
Kemmler G; Holzner B; Kopp M; Dünser M; Margreiter R; Greil R; Sperner-Unterweger B
J Clin Oncol; 1999 Sep; 17(9):2932-40. PubMed ID: 10561373
[TBL] [Abstract][Full Text] [Related]
50. Validation of the Chinese version of EORTC QLQ-BN20 for patients with brain cancer.
Zhang K; Tian J; He Z; Sun W; Pekbay B; Lin Y; Wu D; Zhang J; Chen P; Guo H; Wan Y; Wang M; Yang S; Zheng J; Zhang L
Eur J Cancer Care (Engl); 2018 Mar; 27(2):e12832. PubMed ID: 29461664
[TBL] [Abstract][Full Text] [Related]
51. Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data.
Li L; Mo FK; Chan SL; Hui EP; Tang NS; Koh J; Leung LK; Poon AN; Hui J; Chu CM; Lee KF; Ma BB; Lai PB; Chan AT; Yu SC; Yeo W
BMC Cancer; 2017 Jan; 17(1):8. PubMed ID: 28052758
[TBL] [Abstract][Full Text] [Related]
52. Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial.
Heutte N; Flechtner HH; Mounier N; Mellink WA; Meerwaldt JH; Eghbali H; van't Veer MB; Noordijk EM; Kluin-Nelemans JC; Lampka E; Thomas J; Lugtenburg PJ; Viterbo L; Carde P; Hagenbeek A; van der Maazen RW; Smit WG; Brice P; van Marwijk Kooy M; Baars JW; Poortmans P; Tirelli U; Leeksma OC; Tomsic R; Feugier P; Salles G; Gabarre J; Kersten MJ; Van Den Neste E; Creemers GJ; Gaillard I; Meijnders P; Tertian G; Reman O; Muller HP; Troncy J; Blanc M; Schroyens W; Voogt PJ; Wijermans P; Rieux C; Fermé C; Henry-Amar M;
Lancet Oncol; 2009 Dec; 10(12):1160-70. PubMed ID: 19828373
[TBL] [Abstract][Full Text] [Related]
53. Evaluating quality of life and pulmonary function of long-term survivors of non-small cell lung cancer treated with radical or postoperative radiotherapy.
Ozturk A; Sarihan S; Ercan I; Karadag M
Am J Clin Oncol; 2009 Feb; 32(1):65-72. PubMed ID: 19194128
[TBL] [Abstract][Full Text] [Related]
54. Long-term neurocognitive and other side effects of radiotherapy, with or without chemotherapy, for glioma.
Lawrie TA; Gillespie D; Dowswell T; Evans J; Erridge S; Vale L; Kernohan A; Grant R
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD013047. PubMed ID: 31425631
[TBL] [Abstract][Full Text] [Related]
55. Objective neurocognitive functioning and neurocognitive complaints in patients with high-grade glioma: Evidence of cognitive awareness from the European Organisation for Research and Treatment of Cancer brain tumour clinical trials.
Caramanna I; Bottomley A; Drijver AJ; Twisk J; van den Bent M; Idbaih A; Wick W; Pe M; Klein M; Reijneveld JC;
Eur J Cancer; 2021 Feb; 144():162-168. PubMed ID: 33348088
[TBL] [Abstract][Full Text] [Related]
56. Does it matter how we evaluate HRQOL? Longitudinal comparison of the EORTC QLQ-C30/QLQ-OG25 and FACT-E.
Darling GE; Sulman J; Espin-Garcia O; Trudel JG; Atenafu EG; Kidane B
J Cancer Surviv; 2021 Aug; 15(4):641-650. PubMed ID: 33106994
[TBL] [Abstract][Full Text] [Related]
57. Health-related quality of life in adults with low-grade gliomas: a systematic review.
Rimmer B; Bolnykh I; Dutton L; Lewis J; Burns R; Gallagher P; Williams S; Araújo-Soares V; Menger F; Sharp L
Qual Life Res; 2023 Mar; 32(3):625-651. PubMed ID: 35931881
[TBL] [Abstract][Full Text] [Related]
58. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
[TBL] [Abstract][Full Text] [Related]
59. Prospective assessment of quality of life in adult patients with primary brain tumors in routine neurooncology practice.
Budrukkar A; Jalali R; Dutta D; Sarin R; Devlekar R; Parab S; Kakde A
J Neurooncol; 2009 Dec; 95(3):413-419. PubMed ID: 19548070
[TBL] [Abstract][Full Text] [Related]
60. Quality of life in long-term survivors of oropharynx carcinoma.
Pourel N; Peiffert D; Lartigau E; Desandes E; Luporsi E; Conroy T
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):742-51. PubMed ID: 12377326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]